West Pharmaceutical Services, one of the global leaders in injectable drug administration, has announced the formal opening of its injection molding factory in the Shanghai Qingpu Industrial Zone (SQIZ).
The West Qingpu plant features advanced injection molding technologies in a world-class clean manufacturing environment. West will manufacture TrimTec and InsoCap closures for intravenous solution bottles.
The closures help pharmaceutical companies meet the challenging drug safety standards in China designed to improve delivery of health care services.
West will also export the closures to other markets in Asia, Europe and South America.
The Qingpu plant is approximately 12,000 square meters (about 129,000 square feet) on a 31,590 square meter (7.8 acres) parcel. The plant currently employs 52 people.
Biio Research said West’s sales in 2009 totaled US$1.05 billion.
West supports its customers with sales, manufacturing, customer support and research and development from 50 locations in North and South America, Europe, Asia and Australia. Global headquarters are in Lionville, Pennsylvania, USA.